![Bahija Jallal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bahija Jallal
Vorstandsvorsitzender bei
IMMUNOCORE HOLDINGS PLC
Vermögen: 2 Mio $ am 30.06.2026
Profil
Bahija Jallal currently works at Immunocore Holdings Plc, as Chief Executive Officer & Director from 2019, Immunocore Ltd., as Chief Executive Officer & Director from 2019, Elevance Health, Inc., as Independent Director from 2018, Umb Health Sciences Research Park Corp., as Director, Anthem, Inc. (DSG), as Director, The Johns Hopkins University, as Trustee from 2014, and National Academies of Sciences, as Council Member.
Dr. Jallal also formerly worked at Guardant Health, Inc., as Independent Director from 2019 to 2022, Arrivent BioPharma, Inc., as Director from 2022 to 2024, ADC Therapeutics SA, as Non-Executive Director, Viela Bio, Inc., as Director, Arrivent BioPharma, Inc., as Independent Director from 2022 to 2024, Chiron Corp., as Vice President-Drug Assessment & Development from 2003 to 2006, MedImmune LLC, as President from 2013 to 2019, AstraZeneca PLC, as Executive Vice President from 2013 to 2019, and Association for Women in Science, as President from 2016 to 2018.
Dr. Jallal received her doctorate degree from Université Pierre et Marie Curie.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 13.05.2026 | 5 351 ( 0 % ) | 2 Mio $ | 30.06.2026 | |
IMMUNOCORE HOLDINGS PLC 0,02 % | 02.04.2026 | 12 343 ( 0,02 % ) | 391 890 $ | 30.06.2026 |
Aktive Positionen von Bahija Jallal
| Unternehmen | Position | Beginn |
|---|---|---|
| ELEVANCE HEALTH, INC. | Direktor/Vorstandsmitglied | 01.02.2018 |
| IMMUNOCORE HOLDINGS PLC | Vorstandsvorsitzender | 01.01.2019 |
Anthem, Inc. (DSG) | Direktor/Vorstandsmitglied | - |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Vorstandsvorsitzender | 01.01.2019 |
National Academies of Sciences
 National Academies of Sciences Miscellaneous Commercial ServicesCommercial Services Provides science, technology and health policy advisory services | Corporate Officer/Principal | - |
Umb Health Sciences Research Park Corp.
 Umb Health Sciences Research Park Corp. The Umb Health Sciences Research Park Corp., also known as the BioPark, is a biomedical research park located on the academic medical center campus of the University of Maryland. It is a collaborative campus that houses life science companies and academic research centers focused on commercializing new drugs, diagnostics, and devices, as well as advancing biomedical research. The BioPark offers 250,000 square feet of lab and office space and is a hub for early-stage technology ventures. It is home to several companies, including Gliknik Inc., Vigilant Bioservices, Pharmaron, and Paragon Bioserve, which are dedicated to the discovery and development of novel biomolecules for autoimmune diseases and cancer, and providing secure storage and distribution of tissue and biologic materials for the biotechnology and transplant communities, respectively. Umb Health Sciences Research Park Corp. is based in Baltimore. | Direktor/Vorstandsmitglied | - |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | 01.01.2014 |
Ehemalige bekannte Positionen von Bahija Jallal
| Unternehmen | Position | Ende |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 01.03.2024 |
| ARRIVENT BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 01.01.2024 |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Bahija Jallal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Guardant Health, Inc.
 Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
Elevance Health, Inc.
 Elevance Health, Inc. Managed Health CareHealth Services Provides health plans, clinical, behavioral, pharmacy and complex-care solutions | Health Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association for Women in Science
 Association for Women in Science Miscellaneous Commercial ServicesCommercial Services Promotes womens activities in all scientific fields, from mentoring to scholarships to job listings | Commercial Services |
National Academies of Sciences
National Academies of Sciences Miscellaneous Commercial ServicesCommercial Services Provides science, technology and health policy advisory services | Commercial Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
Umb Health Sciences Research Park Corp.
Umb Health Sciences Research Park Corp. The Umb Health Sciences Research Park Corp., also known as the BioPark, is a biomedical research park located on the academic medical center campus of the University of Maryland. It is a collaborative campus that houses life science companies and academic research centers focused on commercializing new drugs, diagnostics, and devices, as well as advancing biomedical research. The BioPark offers 250,000 square feet of lab and office space and is a hub for early-stage technology ventures. It is home to several companies, including Gliknik Inc., Vigilant Bioservices, Pharmaron, and Paragon Bioserve, which are dedicated to the discovery and development of novel biomolecules for autoimmune diseases and cancer, and providing secure storage and distribution of tissue and biologic materials for the biotechnology and transplant communities, respectively. Umb Health Sciences Research Park Corp. is based in Baltimore. | |
Anthem, Inc. (DSG) | |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Arrivent BioPharma, Inc.
 Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
Wählen Sie MarketScreener 
